CITATION — REFERENCE ENTRY
Papulopustular infantile acne treated with oral isotretinoin — Anais Brasileiros de Dermatologia
- Key
- santos-2023-papulopustular-infantile-acne
- Authors
- Santos, Grasielle Silva; Ianhez, Mayra; Miot, Hélio Amante
- Issued
- 2023
- Type
- article-journal
- Container
- Anais Brasileiros de Dermatologia
Raw CSL JSON
{
"DOI": "10.1016/j.abd.2021.05.026",
"URL": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10173067/",
"type": "article-journal",
"title": "Papulopustular infantile acne treated with oral isotretinoin",
"author": [
{
"given": "Grasielle Silva",
"family": "Santos"
},
{
"given": "Mayra",
"family": "Ianhez"
},
{
"given": "Hélio Amante",
"family": "Miot"
}
],
"issued": {
"date-parts": [
[
2023
]
]
},
"container-title": "Anais Brasileiros de Dermatologia"
}
Claims
-
Santos and colleagues note that oral isotretinoin is off-label at this age, that published doses range from 0.2 to 2.0 mg/kg/day over five to 14 months of treatment, and that androgen testing is mandatory in refractory cases although most are not related to underlying endocrine disease.
"The oral isotretinoin dose for infantile acne varies among publications between 0.2 and 2.0 mg/kg/day, with a total treatment period of five up to 14 months."
Available in